Journal
CURRENT DRUG THERAPY
Volume 12, Issue 1, Pages 46-63Publisher
BENTHAM SCIENCE PUBL LTD
DOI: 10.2174/1574885511666160930121123
Keywords
Tuberculosis; InhA; molecular docking; 3D-QSAR; CoMFA; CoMSIA; imidazo[2,1-b][1,3,4] thiadiazoles; InhA inhibitors
Categories
Funding
- Science and Engineering Research Board (SERB), New Delhi [EMR/2015/000884]
Ask authors/readers for more resources
Background: Trans-2-Enoyl-ACP reductase (InhA) is an established target towards anti-tuberculosis therapy. Objective: Computational studies on imidazo[2,1-b][1,3,4]thiadiazole derivatives as putative InhA inhibitors. Methods: Combined molecular docking and three-dimensional quantitative structure-activity relationship (3D-QSAR) comprising comparative molecular field analysis (CoMFA) and comparative molecular similarity indices analysis (CoMSIA) were performed on imidazo[2,1-b][1,3,4]thiadiazole derivatives as putative InhA inhibitors. Results: Docking analysis reveals that hydrogen bonding, sigma-pi and hydrophobic interactions are the governing factors for anti-TB activity. Furthermore, their best poses were used as an alignment tool for the development of 3D-QSAR models. The CoMFA model exhibited statistically significant results where Leave One Out (LOO) cross-validated (q(2)), non-cross validated (r(2)) and predicted correlation coefficient (r(pred)(2)) values were found to be 0.812, 0.982 and 0.667 respectively, therefore unveiled the important key structural requirements for InhA inhibition. Conclusion: The active site residues GLN100, PRO156, TYR158, LEU197, ALA198, MET199, and LEU218 were identified as crucial binding residues responsible for interactions between inhibitors and InhA. Further, CoMFA analysis theorized that more potent InhA inhibitor could be developed based on proper substitution pattern around the phenyl ring at R-2 and R-3 position. Conclusively, this comprehensive study, an integration of molecular docking and CoMFA analysis provided insights and new predictive tools for structure-based design and optimization of InhA inhibitors.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available